Lipoprotein apheresis – Shortening of treatment intervals reduces cardiovascular events: Case reports
Author:
Funder
European Group – International Society for Apheresis – E-ISFA office
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine
Reference9 articles.
1. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events;Jaeger;Nat Clin Pract Cardiovasc Med,2009
2. Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial;Khan;Eur Heart J,2017
3. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography;Safarova;Atherosclerosis Suppl,2013
4. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?;Kanemitsu;Ther Apher,1998
5. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART);Yamaguchi;Chem Phys Lipids,1994
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3